Participants 48 101 3
psychotic depression in a randomized controlled trial
Participants 214 245 5
patients with major depression.
Participants 443 644 7
pharmacotherapy of MDpsy in patients who participated in the STOPD-PD study, a randomized, double-blind, clinical trial comparing a combination of olanzapine plus sertraline vs. olanzapine plus placebo
Participants 910 1045 3
subjects with a history of no prior treatment or inadequate treatment who were treated with a combination of olanzapine and sertraline.
Participants 1083 1204 3
subjects who had previously failed to respond to an antidepressant alone and who were treated with olanzapine monotherapy
Participants 1248 1353 3
subjects who had previously failed to respond to a combination of an antipsychotic and an antidepressant.
Participants 1482 1502 5
patients with MDpsy.
